Nykode Therapeutics ASA is a clinical-stage biopharmaceutical company which engages in discovering and developing of novel immunotherapies. The company is headquartered in Oslo, Oslo and currently employs 59 full-time employees. The company went IPO on 2020-01-27. Nykode uses its vaccine technology platform to generate therapeutics in disease indications with unmet medical need. The firm develops next generation vaccines for clinical use, based on a deep understanding of immunological principles. Nykode Therapeutics’ main product candidates are VB10.16 and VB10.NEO. VB10.16 is a therapeutic cancer vaccine against HPV16-related cancers. VB10. NEO is a therapeutic cancer neoantigen vaccine. The firm also has two universal COVID-19 vaccine candidates in development.
NYKODE THERAPEUTICS ASA 'in mevcut fiyatı $0.31 'dir, son işlem günde 18.42% azalmış etti.
Nykode Therapeutics AS için ana iş temaları veya sektörler nelerdir?
Nykode Therapeutics AS Biotechnology endüstrisine ait ve sektör Health Care 'dir
Nykode Therapeutics AS 'in piyasa değerlemesi nedir?
Nykode Therapeutics AS 'in mevcut piyasa değerlemesi $101.2M 'dir
Nykode Therapeutics AS al, sat, yoksa beklemeli mi?
Wall Street analistlerine göre, 5 analist Nykode Therapeutics AS için analist derecelendirmeleri gerçekleştirdi, bunlar 0 güçlü al, 0 al, 3 tut, 4 sat ve 0 güçlü sat içermektedir